Skip to main content
Erschienen in: Supportive Care in Cancer 11/2013

01.11.2013 | Review Article

Assessing quality of life in long-term cancer survivors: a review of available tools

verfasst von: Barbara Muzzatti, M. Antonietta Annunziata

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Considering that the number of people with oncological history is constantly growing, and that cancer survivorship has very specific long-term and late (both medical and psychosocial) effects, it seems useful to have specific multidimensional instruments to measure quality of life (QoL). This contribution aims to describe the characteristics and psychometric properties of QoL assessment tools specifically designed for the condition of long-term cancer survivorship.

Methods

We queried the MEDLINE, PsycINFO, and CINAHL databases, which allowed us to identify the pertinent papers, classified by the QoL tool they refer to. We then extracted the characteristics and the psychometric properties from each study.

Results

From the initial 902 papers, 18 meet the selection criteria referring to eight QoL measurements. However, a multipart validation process in order to verify validity and reliability was only started for two of these tools.

Conclusions

Even though clinical practice documents that long-term cancer survivors present with different symptoms and functional challenges compared to patients who are currently undergoing treatment as well as the general population, we still lack a quality of life tool that is specific for them, and that has verified psychometric properties. Even though some of the instruments we described are promising, it is necessary to continue their refinement.
Literatur
1.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 suppl):2577–2592PubMedCrossRef Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 suppl):2577–2592PubMedCrossRef
2.
Zurück zum Zitat Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eu J Cancer Care (English) 18:223–247CrossRef Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eu J Cancer Care (English) 18:223–247CrossRef
3.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef
4.
Zurück zum Zitat Annunziata MA, Muzzatti B, Bianchet K, Berretta M, Chimienti E, Lleshi A, Tirelli U (2009) Sopravvivere al cancro: una rassegna sulla qualità di vita nella cancer survivorship. Psicologia della Salute 10:55–71 Annunziata MA, Muzzatti B, Bianchet K, Berretta M, Chimienti E, Lleshi A, Tirelli U (2009) Sopravvivere al cancro: una rassegna sulla qualità di vita nella cancer survivorship. Psicologia della Salute 10:55–71
5.
Zurück zum Zitat Tedeschi RG, Calhoun LG (1996) The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Traumatic Stress 9:455–472CrossRef Tedeschi RG, Calhoun LG (1996) The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Traumatic Stress 9:455–472CrossRef
6.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMedCrossRef Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMedCrossRef
7.
Zurück zum Zitat Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Wilder Smith A, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A (2006) Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors. Oncology 70:190–202PubMedCrossRef Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Wilder Smith A, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A (2006) Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors. Oncology 70:190–202PubMedCrossRef
8.
Zurück zum Zitat Zhao L, Portier K, Stein K, Baker F, Smith T (2009) Exploratory factor analysis of the Cancer Problems in Living Scale: a report from the American Cancer Society's Studies of Cancer Survivors. J Pain Symptom Manage 37:676–686PubMedCrossRef Zhao L, Portier K, Stein K, Baker F, Smith T (2009) Exploratory factor analysis of the Cancer Problems in Living Scale: a report from the American Cancer Society's Studies of Cancer Survivors. J Pain Symptom Manage 37:676–686PubMedCrossRef
9.
Zurück zum Zitat Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L (2006) Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncol 15:407–421CrossRef Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L (2006) Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncol 15:407–421CrossRef
10.
Zurück zum Zitat Dahl HA, Gudbergsson SB, Dørum A, Fossa SD, Liavaag AH, Sørebø Ø (2011) The impact of cancer scale version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors. Qual Life Res. doi:10.1007/s11136-011-0053-y PubMed Dahl HA, Gudbergsson SB, Dørum A, Fossa SD, Liavaag AH, Sørebø Ø (2011) The impact of cancer scale version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors. Qual Life Res. doi:10.​1007/​s11136-011-0053-y PubMed
11.
Zurück zum Zitat Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the Impact of Cancer Scale. J Natl Cancer Inst 100:1530–1541PubMedCrossRef Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the Impact of Cancer Scale. J Natl Cancer Inst 100:1530–1541PubMedCrossRef
12.
Zurück zum Zitat Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA (2010) Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv 4:45–58PubMedCrossRef Crespi CM, Smith SK, Petersen L, Zimmerman S, Ganz PA (2010) Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors. J Cancer Surviv 4:45–58PubMedCrossRef
13.
Zurück zum Zitat Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA (2012) Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncol. doi:10.1002/pon.3131 Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA (2012) Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psycho-Oncol. doi:10.​1002/​pon.​3131
14.
Zurück zum Zitat Crespi CM, Ganz PA, Petersen L, Smith SK (2013) A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses. Qual Life Res 22(1):103–109PubMedCrossRef Crespi CM, Ganz PA, Petersen L, Smith SK (2013) A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses. Qual Life Res 22(1):103–109PubMedCrossRef
15.
Zurück zum Zitat Wyatt G, Kurtz ME, Friedman LL, Given B, Given CW (1996) Preliminary testing of the Long-Term Quality of Life (LTQL) instrument for female cancer survivors. J Nurs Meas 4:153–170PubMed Wyatt G, Kurtz ME, Friedman LL, Given B, Given CW (1996) Preliminary testing of the Long-Term Quality of Life (LTQL) instrument for female cancer survivors. J Nurs Meas 4:153–170PubMed
16.
Zurück zum Zitat Gordon NH, Siminoff LA (2010) Measuring quality of life of long-term breast cancer survivors: the Long Term Quality of Life-Breast Cancer (LTQOL-BC) Scale. J Psychosoc Oncol 28:589–609PubMedCrossRef Gordon NH, Siminoff LA (2010) Measuring quality of life of long-term breast cancer survivors: the Long Term Quality of Life-Breast Cancer (LTQOL-BC) Scale. J Psychosoc Oncol 28:589–609PubMedCrossRef
17.
Zurück zum Zitat Ferrell BR, Hassey Dow K, Leigh S, Ly J, Gulasekaram P (1995) Quality of life in long-term cancer survivors. Oncol Nurs Forum 22:915–922PubMed Ferrell BR, Hassey Dow K, Leigh S, Ly J, Gulasekaram P (1995) Quality of life in long-term cancer survivors. Oncol Nurs Forum 22:915–922PubMed
18.
Zurück zum Zitat Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531PubMedCrossRef Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531PubMedCrossRef
19.
Zurück zum Zitat Fujimori M, Kobayakawa M, Nakaya N, Nagai K, Nishiwaki Y, Inagaki M, Uchitomi Y (2006) Psychometric properties of the Japanese version of the Quality of Life-Cancer Survivors Instrument. Qual Life Res 15:1633–1638PubMedCrossRef Fujimori M, Kobayakawa M, Nakaya N, Nagai K, Nishiwaki Y, Inagaki M, Uchitomi Y (2006) Psychometric properties of the Japanese version of the Quality of Life-Cancer Survivors Instrument. Qual Life Res 15:1633–1638PubMedCrossRef
20.
Zurück zum Zitat van Dis FW, Mols F, Vingerhoets Ad JJM, Ferrell B, van de Poll-Franse LV (2006) A validation study of the Dutch version of the Quality of Life-Cancer Survivor (QOL-CS) Questionnaire in a group of prostate cancer survivors. Qual Life Res 15:1607–1612PubMedCrossRef van Dis FW, Mols F, Vingerhoets Ad JJM, Ferrell B, van de Poll-Franse LV (2006) A validation study of the Dutch version of the Quality of Life-Cancer Survivor (QOL-CS) Questionnaire in a group of prostate cancer survivors. Qual Life Res 15:1607–1612PubMedCrossRef
21.
Zurück zum Zitat Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS (2005) Assessing Quality of Life in Adult Cancer Survivors (QLACS). Qual Life Res 14:1007–1023PubMedCrossRef Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver CS (2005) Assessing Quality of Life in Adult Cancer Survivors (QLACS). Qual Life Res 14:1007–1023PubMedCrossRef
22.
Zurück zum Zitat Avis NE, Ip E, Foley KL (2006) Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qua Life Outcomes 1:92CrossRef Avis NE, Ip E, Foley KL (2006) Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qua Life Outcomes 1:92CrossRef
23.
Zurück zum Zitat Baker F, Denniston M, Hann D, Gesme D, Reding DJ, Flynn T, Kennedy JS (2007) Factor structure and concurrent validity of the Satisfaction with Life Domains Scale for Cancer (SLDS-C). J Psychosoc Oncol 25:1–17CrossRef Baker F, Denniston M, Hann D, Gesme D, Reding DJ, Flynn T, Kennedy JS (2007) Factor structure and concurrent validity of the Satisfaction with Life Domains Scale for Cancer (SLDS-C). J Psychosoc Oncol 25:1–17CrossRef
24.
Zurück zum Zitat Baker F, Denniston M, Zabora JR, Marcellus D (2003) Cancer problems in living and quality of life after bone marrow transplantation. J Clin Psychol Medical Settings 10:27–34CrossRef Baker F, Denniston M, Zabora JR, Marcellus D (2003) Cancer problems in living and quality of life after bone marrow transplantation. J Clin Psychol Medical Settings 10:27–34CrossRef
25.
Zurück zum Zitat Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC (2008) Post-traumatic stress outcomes in non-Hodgkin's lymphoma survivors. J Clin Oncol 26:934–941PubMedCrossRef Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC (2008) Post-traumatic stress outcomes in non-Hodgkin's lymphoma survivors. J Clin Oncol 26:934–941PubMedCrossRef
26.
Zurück zum Zitat Ferrell BR (1993) Overview of breast cancer: quality of life. Oncol Patient Care 15:7–8 Ferrell BR (1993) Overview of breast cancer: quality of life. Oncol Patient Care 15:7–8
27.
Zurück zum Zitat Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84:575–579PubMedCrossRef Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84:575–579PubMedCrossRef
28.
Zurück zum Zitat Baker R, Curbow BA, Wingard JR (1992) Development of the satisfaction with life domains scale for cancer. J Psychosoc Oncol 70:75–90 Baker R, Curbow BA, Wingard JR (1992) Development of the satisfaction with life domains scale for cancer. J Psychosoc Oncol 70:75–90
29.
Zurück zum Zitat Fayers PM, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes (II edition). Wiley, Chichester Fayers PM, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes (II edition). Wiley, Chichester
30.
Zurück zum Zitat Lipscomb J, Gotay CC, Snyder C (eds) (2005) Outcomes assessment in cancer: measures, methods and applications. Cambridge University Press, Cambridge Lipscomb J, Gotay CC, Snyder C (eds) (2005) Outcomes assessment in cancer: measures, methods and applications. Cambridge University Press, Cambridge
32.
Zurück zum Zitat Annunziata MA, Muzzatti B, Giovannini L, Bianchet K, Berretta M, Lleshi A, Tirelli U, Grassi L (2010) Defining cancer survivorship: clinical and research implications. PsychoOncol 19(s2):226–227 Annunziata MA, Muzzatti B, Giovannini L, Bianchet K, Berretta M, Lleshi A, Tirelli U, Grassi L (2010) Defining cancer survivorship: clinical and research implications. PsychoOncol 19(s2):226–227
33.
Zurück zum Zitat Cronbach L (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334CrossRef Cronbach L (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334CrossRef
34.
Zurück zum Zitat Pearce NJM, Sanson-Fisher R, Campbell HS (2008) Measuring quality of life in cancer survivors: a methodological review of existing scales. Psycho-Oncol 17:629–640CrossRef Pearce NJM, Sanson-Fisher R, Campbell HS (2008) Measuring quality of life in cancer survivors: a methodological review of existing scales. Psycho-Oncol 17:629–640CrossRef
Metadaten
Titel
Assessing quality of life in long-term cancer survivors: a review of available tools
verfasst von
Barbara Muzzatti
M. Antonietta Annunziata
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1912-6

Weitere Artikel der Ausgabe 11/2013

Supportive Care in Cancer 11/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.